Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing.

Reagan JL, Ingham RR 2nd, Dalia S, Butera JN, Sweeney JD.

Thromb Res. 2014 Jul;134(1):90-2. doi: 10.1016/j.thromres.2014.04.030. Epub 2014 May 2.

PMID:
24830900
2.

Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.

Sylvester KW, Fanikos J, Anger KE, Matta L, Southard RA, Beik N, Lemire SJ, Dorfman DM, Berliner N.

Pharmacotherapy. 2013 Nov;33(11):1191-8. doi: 10.1002/phar.1322. Epub 2013 Jun 27.

PMID:
23813781
3.

What is the potential for overdiagnosis of heparin-induced thrombocytopenia?

Lo GK, Sigouin CS, Warkentin TE.

Am J Hematol. 2007 Dec;82(12):1037-43.

4.

Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.

Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE.

J Thromb Haemost. 2007 Aug;5(8):1666-73. Epub 2007 May 7.

5.

Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients.

Hourigan LA, Walters DL, Keck SA, Dec GW.

J Heart Lung Transplant. 2002 Dec;21(12):1283-9.

PMID:
12490273
6.

Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.

Legnani C, Cini M, Pili C, Boggian O, Frascaro M, Palareti G.

Thromb Haemost. 2010 Aug;104(2):402-9. doi: 10.1160/TH10-01-0002. Epub 2010 Jun 10.

PMID:
20539902
7.

Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia.

Lindhoff-Last E, Gerdsen F, Ackermann H, Bauersachs R.

Br J Haematol. 2001 Jun;113(4):886-90.

PMID:
11442479
8.

Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost.

Smythe MA, Koerber JM, Mehta TP, Forsyth LL, Conger E, Corbets LR, Mattson JC.

Thromb Haemost. 2012 Nov;108(5):992-8. doi: 10.1160/TH12-05-0289. Epub 2012 Sep 5.

PMID:
22955669
9.
10.

Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.

Berry C, Tcherniantchouk O, Ley EJ, Salim A, Mirocha J, Martin-Stone S, Stolpner D, Margulies DR.

J Am Coll Surg. 2011 Jul;213(1):10-7; discussion 17-8. doi: 10.1016/j.jamcollsurg.2011.04.002. Epub 2011 May 4.

PMID:
21531584
11.

False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus.

Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U.

J Thromb Haemost. 2009 Jul;7(7):1070-4. doi: 10.1111/j.1538-7836.2009.03335.x. Epub 2009 Mar 5.

12.

Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.

Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, Warkentin TE, Greinacher A.

J Thromb Haemost. 2010 Jan;8(1):30-6. doi: 10.1111/j.1538-7836.2009.03626.x. Epub 2009 Sep 28.

13.

Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.

Pouplard C, Leroux D, Regina S, Rollin J, Gruel Y.

Thromb Haemost. 2010 Jan;103(1):145-50. doi: 10.1160/TH09-04-0253. Epub 2009 Sep 30.

PMID:
20062918
14.

Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia.

Althaus K, Hron G, Strobel U, Abbate R, Rogolino A, Davidson S, Greinacher A, Bakchoul T.

Thromb Res. 2013 Mar;131(3):e85-90. doi: 10.1016/j.thromres.2013.01.005. Epub 2013 Jan 23.

PMID:
23351665
16.

Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.

Selleng S, Malowsky B, Itterman T, Bagemühl J, Wessel A, Wollert HG, Warkentin TE, Greinacher A.

Am Heart J. 2010 Aug;160(2):362-9. doi: 10.1016/j.ahj.2010.05.026.

PMID:
20691844
17.

Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia.

Wirth SM, Macaulay TE, Armitstead JA, Steinke DT, Blechner MD, Lewis DA.

J Oncol Pharm Pract. 2010 Sep;16(3):161-6. doi: 10.1177/1078155209342133. Epub 2009 Aug 19.

PMID:
19692430
18.

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG.

J Lab Clin Med. 2005 Dec;146(6):341-6.

PMID:
16310517
19.

Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT).

Bakchoul T, Giptner A, Bein G, Santoso S, Sachs UJ.

Thromb Res. 2011 Apr;127(4):345-8. doi: 10.1016/j.thromres.2010.12.001. Epub 2011 Jan 12.

PMID:
21232785
20.

Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit.

Pierce W, Mazur J, Greenberg C, Mueller J, Foster J, Lazarchick J.

Ann Clin Lab Sci. 2013 Fall;43(4):429-35.

PMID:
24247801

Supplemental Content

Support Center